Publication Date: 31 Jul 2013
Type: Review
Journal: Clinical Medicine Insights: Dermatology
Citation: Clinical Medicine Insights: Dermatology 2013:6 19-25
doi: 10.4137/CMD.S11337
Psoriasis is a common, chronic, inflammatory disease affecting millions of people around the world. Presented in the first 5 parts of the American Academy of Dermatology Psoriasis Guidelines of Care is evidence supporting the use of topical treatments, phototherapy, traditional systemic agents, and biological therapies for patients with psoriasis.
Biological therapy is a new, safe, and effective treatment for moderate to severe psoriasis. This type of medication is designed to target specific components of the immune system. There is a need to review the recommended treatment guidelines for psoriasis because the perception and demands of patients are constantly changing. In future, this class of drugs will expand as new biologics are being developed. In this review, we emphasize the description of psoriasis and therapy scheme for mild to severe forms and options (classification according to the manifestation of the disease or to the application form) for biological treatment.
PDF (565.15 KB PDF FORMAT)
RIS citation (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)
BibTex citation (BIBDESK, LATEX)
I highly recommend publication in Libertas Academia journals. The entire submission, review and publication process for our article in Clinical Medicine Insights: Dermatology was easy and quick. The reviews were very professional and helpful and the publication fees were reasonable. We also appreciate that our article is available online free of charge to anyone interested in it.
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.See Our Results
Copyright © 2014 Libertas Academica Ltd (except open access articles and accompanying metadata and supplementary files.)
Facebook Google+ Twitter
Pinterest Tumblr YouTube